Biopharma Excellence Awards (BEA) 2024 exists to recognize exceptional biologics and vaccine experts, organizations and technologies that facilitate vaccine R&D and biologics manufacturing excellence in Developing Economies & India at enhanced speed, reduced cost, and superior quality.
Featuring top vaccine and biomanufacturing leaders in the industry, along with the latest advances in technologies and best practices in R&D and manufacturing, the Biopharma Excellence Awards 2024 applauds extraordinary leaders & trend-setters of today and inspires innovators of tomorrow.
The Awards Ceremony will be held in conjunction with the 14th Vaccines World Summit and 3rd Great Indian Biologics Festival 2024 on the 23rd of Jan 2024 at Novotel Hyderabad.
How does it work?
IMAPAC Biologics, the organizing committee of BEA 2024 has called for nominations from the IMAPAC biologics community for different biologics award categories. Based on the number of nominations and assessment, the top 5 entries under each category are shortlisted. From the top 5 entries, the award winner will be determined by 100 % voting results from the public or biologics community.
TIMELINE OF AWARDS
Criteria for nomination
THE CRITERIA FOR A COMPANY TO BE ELIGIBLE FOR BEA EXCELLENCE AWARDS 2024 ARE:
- The company / institute should be an organization that is involved in biopharmaceutical R&D development and/or manufacturing with a notable presence in India and/or Developing Economies as applicable
- The company should have displayed significant developments in the past few years
Criteria to win the awards
Based on the number of nominations and assessment, the top 5-7 entries under each category are shortlisted. From the top 5-7 entries, the award winner will be determined by 100 % voting results from the Biologics community. Companies with the most number of votes will win the award in their respective category.
